Zydus Cadila launches 70% less costly generic prostate cancer drug

Drug firm Zydus Cadila has launched generic Enzalutamide capsules to use in treatment of prostate cancer. The price of the drug is over 70 per cent less than the available similar products, especially in India. Zydus Cadila has launched this product under the brand name ‘Obnyx’.

Priced at Rs 23,980 per month, the drug offers bio-availability advantages in a soft gel capsule and it’s different from the hard gelatin capsules available in the country, it added. Developed in-house, the drug offers bio-availability advantages in a soft gel capsule, different from the hard gelatin capsules available in the country